Evidence map›Paper›PMID 37059931›Full record

ArticleMolecular neurobiology2023

Role of TPEN in Amyloid-β

Wen-Bo Chen, Yu-Xiang Wang, Hong-Gang Wang, Di An, Dan Sun, Pan Li, Tao Zhang, Wan-Ge Lu, Yan-Qiang Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wen-Bo ChenCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Yu-Xiang WangDepartment of Immunology and Pathogenic Biology, School of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, 050200, Hebei, China.
Hong-Gang WangCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Di AnCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Dan SunCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Pan LiTianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgery Institute, Department of Neurology, Tianjin Huanhu Hospital Affiliated to Nankai University, Tianjin, China.
Tao ZhangCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Wan-Ge LuCollege of Life Sciences, Nankai University, Tianjin, 300071, China.
Yan-Qiang LiuCollege of Life Sciences, Nankai University, Tianjin, 300071, China. liuyanq@nankai.edu.cn.ORCID http://orcid.org/0000-0003-4296-728X
Nankai University · CNHebei University of Chinese Medicine · CNHenan University · CN

Funding

National Natural Science Foundation of China 31272317Natural Science Foundation of Tianjin City 20JCYBJC01370
6 · The paper itself

Abstract

The overproduction of neurotoxic amyloid-β (Aβ) peptides in the brain is a hallmark of Alzheimer's disease (AD). To determine the role of intracellular zinc ion (

Indexed as

Amyloid beta-PeptidesNeuronsApoptosisChelating AgentsEthylenediaminesPeptide FragmentsReactive Oxygen SpeciesRNA, MessengerZincAmyloid beta-PeptidesChelating AgentsEthylenediaminesN,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediaminePeptide FragmentsReactive Oxygen SpeciesRNA, MessengerZincAβ25–35Calcium ions signalOrganelle damageROSTPENZinc ions

Identifiers

PMID37059931
OpenAlexW4365504538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.